322 related articles for article (PubMed ID: 26289794)
1. Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003-2013.
Mosnier A; Caini S; Daviaud I; Bensoussan JL; Stoll-Keller F; Bui TT; Lina B; Van der Werf S; Cohen JM;
BMC Infect Dis; 2015 Aug; 15():357. PubMed ID: 26289794
[TBL] [Abstract][Full Text] [Related]
2. Influenza surveillance in Western Turkey in the era of quadrivalent vaccines: A 2003-2016 retrospective analysis.
Meşe S; Uyanik A; Özakay A; Öztürk S; Badur S
Hum Vaccin Immunother; 2018; 14(8):1899-1908. PubMed ID: 29543569
[TBL] [Abstract][Full Text] [Related]
3. Circulation of influenza A and B in the Czech Republic from 2000-2001 to 2015-2016.
Havlickova M; Druelles S; Jirincova H; Limberkova R; Nagy A; Rasuli A; Kyncl J
BMC Infect Dis; 2019 Feb; 19(1):160. PubMed ID: 30764763
[TBL] [Abstract][Full Text] [Related]
4. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
5. Using surveillance to evaluate influenza vaccine effectiveness.
Jackson LA
J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
[No Abstract] [Full Text] [Related]
6. Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.
Brammer TL; Murray EL; Fukuda K; Hall HE; Klimov A; Cox NJ
MMWR Surveill Summ; 2002 Oct; 51(7):1-10. PubMed ID: 12418623
[TBL] [Abstract][Full Text] [Related]
7. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
Chung JR; Kim SS; Kondor RJ; Smith C; Budd AP; Tartof SY; Florea A; Talbot HK; Grijalva CG; Wernli KJ; Phillips CH; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Reis M; Geffel KM; Nowalk MP; DaSilva J; Keong LM; Stark TJ; Barnes JR; Wentworth DE; Brammer L; Burns E; Fry AM; Patel MM; Flannery B
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):365-370. PubMed ID: 35271561
[TBL] [Abstract][Full Text] [Related]
8. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP
PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951
[TBL] [Abstract][Full Text] [Related]
9. The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century.
Caini S; Kusznierz G; Garate VV; Wangchuk S; Thapa B; de Paula Júnior FJ; Ferreira de Almeida WA; Njouom R; Fasce RA; Bustos P; Feng L; Peng Z; Araya JL; Bruno A; de Mora D; Barahona de Gámez MJ; Pebody R; Zambon M; Higueros R; Rivera R; Kosasih H; Castrucci MR; Bella A; Kadjo HA; Daouda C; Makusheva A; Bessonova O; Chaves SS; Emukule GO; Heraud JM; Razanajatovo NH; Barakat A; El Falaki F; Meijer A; Donker GA; Huang QS; Wood T; Balmaseda A; Palekar R; Arévalo BM; Rodrigues AP; Guiomar R; Lee VJM; Ang LW; Cohen C; Treurnicht F; Mironenko A; Holubka O; Bresee J; Brammer L; Le MTQ; Hoang PVM; El Guerche-Séblain C; Paget J;
PLoS One; 2019; 14(9):e0222381. PubMed ID: 31513690
[TBL] [Abstract][Full Text] [Related]
10. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
[TBL] [Abstract][Full Text] [Related]
11. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
[TBL] [Abstract][Full Text] [Related]
13. [Influenza surveillance in five consecutive seasons during post pandemic period: results from National Influenza Center, Turkey].
Altaş AB; Bayrakdar F; Korukluoğlu G
Mikrobiyol Bul; 2016 Jul; 50(3):401-17. PubMed ID: 27525396
[TBL] [Abstract][Full Text] [Related]
14. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
15. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
[TBL] [Abstract][Full Text] [Related]
16. [The 2001/2002 influenza season and the vaccine composition for the 2002/2003 season].
Rimmelzwaan GF; de Jong JC; Bartelds AI; Wilbrink B; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1846-50. PubMed ID: 12382372
[TBL] [Abstract][Full Text] [Related]
17. [The 2003/2004 influenza season in the Netherlands with a limited epidemic of the virus variant A/Fujian, and the vaccine composition for the 2004/2005 season].
Rimmelzwaan GF; de Jong JC; Bartelds AI; Wilbrink B; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1984-8. PubMed ID: 15524136
[TBL] [Abstract][Full Text] [Related]
18. Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.
Dawood FS; Chung JR; Kim SS; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Dunnigan K; Foust A; Sessions W; DaSilva J; Le S; Stark T; Kondor RJ; Barnes JR; Wentworth DE; Brammer L; Fry AM; Patel MM; Flannery B
MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(7):177-182. PubMed ID: 32078591
[TBL] [Abstract][Full Text] [Related]
19. [Influenza surveillance in nine consecutive seasons, 2003-2012: results from National Influenza Reference Laboratory, Istanbul Faculty Of Medicine, Turkey].
Akçay Ciblak M; Kanturvardar Tütenyurd M; Asar S; Tulunoğlu M; Fındıkçı N; Badur S
Mikrobiyol Bul; 2012 Oct; 46(4):575-93. PubMed ID: 23188572
[TBL] [Abstract][Full Text] [Related]
20. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.
Doyle JD; Chung JR; Kim SS; Gaglani M; Raiyani C; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Foust A; Sessions W; Berman L; Garten RJ; Barnes JR; Wentworth DE; Fry AM; Patel MM; Flannery B
MMWR Morb Mortal Wkly Rep; 2019 Feb; 68(6):135-139. PubMed ID: 30763298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
